To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in 10x Genomics, Inc. by 9,210 shares, the number of shares held decreased 0.37% compared to the previous period and now represents 9.64% of the total position.
      2Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 8,115 shares, the number of shares held decreased 0.37% compared to the previous period and now represents 2.98% of the total position.
      20Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in CareDx by 5,439 shares, the number of shares held decreased 0.37% compared to the previous period and now represents 4.16% of the total position.
      1Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 9,531 shares, the number of shares held decreased 0.37% compared to the previous period and now represents 1.44% of the total position.
      1Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Nurix Therapeutics by 6,252 shares, the number of shares held decreased 0.37% compared to the previous period and now represents 1.84% of the total position.
      1Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Veracyte by 3,816 shares, the number of shares held decreased 0.37% compared to the previous period and now represents 2.31% of the total position.
      7Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Adaptive Biotechnologies Corp by 6,597 shares, the number of shares held decreased 0.37% compared to the previous period and now represents 2.43% of the total position.
      126Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Ionis Pharmaceuticals by 3,150 shares, the number of shares held decreased 0.37% compared to the previous period and now represents 1.72% of the total position.
      2Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Alamar Biosciences by 3,558 shares, the number of shares held decreased 0.37% compared to the previous period and now represents 1.47% of the total position.
      49Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in COMPASS Pathways plc by 16,593 shares, the number of shares held decreased 0.37% compared to the previous period and now represents 2.7% of the total position.
      1Comment
      Report
       
       
       
       

      Most Discussed